Advertisement
News
Advertisement

Growth Hormone Deficiency Global Clinical Trials Review, Q2, 2011

Wed, 07/06/2011 - 9:39am
Bio-Medicine.Org

NEW YORK, July 6, 2011 /PRNewswire/ -- Reportlinker.com announces that a new market research report is available in its catalogue:

Growth Hormone Deficiency Global Clinical Trials Review, Q2, 2011

http://www.reportlinker.com/p0567405/Growth-Hormone-Deficiency-Global-Clinical-Trials-Review-Q2-2011.html#utm_source=prnewswire&utm_medium=pr&utm_campaign=Drug_Discovery_and_Development

Growth Hormone Deficiency Global Clinical Trials Review, Q2, 2011

Summary

GlobalData's clinical trial report, "Growth Hormone Deficiency Global Clinical Trials Review, Q2, 2011" provides data on the Growth Hormone Deficiency clinical trial scenario. This report provides elemental information and data relating to the clinical trials on Growth Hormone Deficiency. It includes an overview of the trial numbers and their recruitment status as per the site of trial conduction across the globe. The databook offers a preliminary coverage of disease clinical trials by their phase, trial status, prominence of the sponsors and also provides briefing pertaining to the number of trials for the key drugs for treating Growth Hormone Deficiency. This report is built using data and information sourced from proprietary databases, primary and secondary research and in-house analysis by GlobalData's team of industry experts.

Note: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.

Scope

- Data on the number of clinical trials conducted in North America, South and Central America, Europe, Middle-East and Africa and Asia-pacific and

'/>"/>

SOURCE

Topics

Advertisement

Share this Story

X
You may login with either your assigned username or your e-mail address.
The password field is case sensitive.
Loading